Genome News and Research

RSS

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Diabetes, a metabolic disease, is on the rise worldwide, and over 90 percent of cases are type 2 diabetes, where the body does not effectively respond to insulin.

14 Jan 2026

Specific foods linked to autism risk via immune pathways

Genetic and clinical data suggest dietary factors may influence autism risk via immune pathways, highlighting the need for further research in this area.

14 Jan 2026

Genomic analysis reveals diverse, drug-resistant E. coli in diabetic foot infections

New research led by King's College London, in collaboration with the University of Westminster, has shed light on the diversity and characteristics of E. coli strains that drive diabetic foot infections.

13 Jan 2026

OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.

12 Jan 2026

Two harmful gene variants can combine to restore normal protein function

In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific Northwest Research Institute (PNRI) have overturned a long-held belief in genetics: that inheriting two harmful variants in the same gene always worsens disease.

12 Jan 2026

Whole-genome sequencing improves PARP inhibitor treatment prediction

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

12 Jan 2026

Personalized cancer therapy significantly enhances treatment success

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based on the unique DNA of a patient's tumor.

12 Jan 2026

Key protein in the tuberculosis bacterium helps protect itself from foreign DNA

Researchers at the Indian Institute of Science (IISc), with collaborators from the Institute of Mathematical Sciences (IMSc), have discovered how a key protein in the tuberculosis bacterium helps protect it from the influence of foreign DNA inserted into its genome.

9 Jan 2026

Non-coding RNA mutations unveiled as new cause of retinitis pigmentosa

Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with night blindness in youth and progresses to tunnel vision as daylight-sensing photoreceptor cells in the retina gradually die, potentially leading to blindness over time.

9 Jan 2026

New research decodes the bacterial “zip code” of colorectal cancer for prediction and survival

Bacterial communities in colorectal cancer reveal patterns linked to tumor genetics and patient outcomes, paving the way for personalized treatment strategies.

From BGI Genomics 9 Jan 2026

Individualized drug combinations improve cancer treatment outcomes

8 Jan 2026

Clonal hematopoiesis linked to increased heart disease risk in cancer patients receiving treatment

About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP).

8 Jan 2026

Why promising microbiome therapies rarely work in patients

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.

8 Jan 2026

New DNA tests reveal hidden biological traces on Renaissance art

DNA analysis of cultural artifacts shows diverse biological profiles, but contamination and mixed signals complicate historical lineage interpretation.

8 Jan 2026

Sugarcane protein mouthwash helps protect oral health during head and neck cancer treatment

An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in a laboratory, can aid in treating teeth in patients with head and neck cancer. In these cases, radiotherapy very close to the mouth can destroy salivary glands and compromise saliva production, which is essential for controlling bacteria and disease.

7 Jan 2026

Breast milk bacteria help shape infant gut microbiome development

Most conversations about breast milk tend to focus on topics like nutrients, antibodies and bonding time rather than bacteria.

7 Jan 2026

Single-dose oral cholera vaccine shows promising results in early clinical trial

Clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera cases worldwide.

7 Jan 2026

Genetic study reveals how DNA repeats expand with age

An analysis of genetic data from over 900,000 people shows that certain stretches of DNA, made up of short sequences repeated over and over, become longer and more unstable as we age.

7 Jan 2026

A single immune protein may help explain why kidney and heart disease often develop together

This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are strongly associated with kidney, cardiovascular, and metabolic disease risk. It highlights suPAR as a stable biomarker of innate immune activation with potential pathogenic roles, while underscoring major gaps in assay standardization and therapeutic validation.

6 Jan 2026

Ancient animals reveal sleep’s original role in maintaining brain health

A groundbreaking new study from Bar-Ilan University shows that one of sleep's core functions originated hundreds of millions of years ago in jellyfish and sea anemones, among the earliest creatures with nervous systems.

6 Jan 2026

Genome News and Research

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Specific foods linked to autism risk via immune pathways

Genomic analysis reveals diverse, drug-resistant E. coli in diabetic foot infections

OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate

Two harmful gene variants can combine to restore normal protein function

Whole-genome sequencing improves PARP inhibitor treatment prediction

Personalized cancer therapy significantly enhances treatment success

Key protein in the tuberculosis bacterium helps protect itself from foreign DNA

Non-coding RNA mutations unveiled as new cause of retinitis pigmentosa

New research decodes the bacterial “zip code” of colorectal cancer for prediction and survival

Individualized drug combinations improve cancer treatment outcomes

Clonal hematopoiesis linked to increased heart disease risk in cancer patients receiving treatment

Why promising microbiome therapies rarely work in patients

New DNA tests reveal hidden biological traces on Renaissance art

Sugarcane protein mouthwash helps protect oral health during head and neck cancer treatment

Breast milk bacteria help shape infant gut microbiome development

Single-dose oral cholera vaccine shows promising results in early clinical trial

Genetic study reveals how DNA repeats expand with age

A single immune protein may help explain why kidney and heart disease often develop together

Ancient animals reveal sleep’s original role in maintaining brain health

The art of CRISPR: The power and promise of gene editing eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News